Inactive Instrument

All News Biondvax Pharmaceuticals Ltd

Equities

IL0011052045

End-of-day quote TEL AVIV STOCK EXCHANGE Other stock markets
- ^ILa	-

All News

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Biondvax Pharmaceuticals : Announces Rights Offering Fully Subscribed at US$20 Million	19-07-16	PU
Biondvax Pharmaceuticals : First Participant Enrolled in Second Cohort of BiondVax’s Pivotal, Clinical Efficacy, Phase 3 Universal Flu Vaccine Trial	19-07-08	PU
Biondvax Pharmaceuticals : European Investment Bank VP attends Signature Event at BiondVax Extending Financing Agreement with BiondVax to €24 million	19-06-26	PU
Biondvax Pharmaceuticals : Patent Covering Manufacturing Process of BiondVax’s M-001 Universal Flu Vaccine Allowed in USA and Japan	19-06-18	PU
Biondvax Pharmaceuticals : Announces Rights Offering in Support of Ongoing Pivotal, Clinical Efficacy Phase 3 Trial of the M-001 Universal Flu Vaccine and Scale Up of Manufacturing Process	19-06-10	PU
Biondvax Pharmaceuticals : European Investment Bank (EIB) extends financing agreement to €24 million total in support of BiondVax’s universal flu vaccine ongoing pivotal Phase 3 clinical trial	19-04-22	PU
Biondvax Pharmaceuticals : Last participant out in USA Phase 2 clinical trial of BiondVax’s M-001 Universal Influenza Vaccine candidate	19-03-21	PU
Biondvax Pharmaceuticals : CEO to Present at “World Vaccine Congress 2018 San Diego” about ’s Phase 3 Universal Flu Vaccine Candidate	18-11-26	PU
Biondvax Pharmaceuticals : Announces Third Quarter 2018 Financial Results	18-11-13	PU
Biondvax Pharmaceuticals : Universal Flu Vaccine Phase 3 Clinical Trial Completes First Season’s Enrollment of 4,098 Participants	18-10-24	PU
Biondvax Pharmaceuticals : Corporate Biotech Executive Mark Germain Joins BiondVax’s Board of Directors	18-06-28	PU
Biondvax Pharmaceuticals : CEO Issues Letter to Shareholders	17-12-05	PU
Biondvax Pharmaceuticals : Provides Third Quarter 2017 Financial Results and Update	17-11-28	PU
Biondvax Pharmaceuticals : and NIH sign Clinical Trial Agreement for a Phase 2 trial in the U.S. with ’s Universal Flu Vaccine	17-11-20	PU
Biondvax Pharmaceuticals : Announces Pricing of Public Offering of American Depositary Shares	17-09-13	PU
Biondvax Pharmaceuticals : Announces Public Offering of American Depositary Shares	17-09-13	PU
Biondvax Pharmaceuticals : Reports Positive Phase 2b Clinical Trial Results for its Universal Flu Vaccine	17-07-20	PU
Biondvax Pharmaceuticals : CEO Provides First Half 2017 General Corporate Update	17-06-28	PU
Biondvax Pharmaceuticals : European Investment Bank (EIB) supports Late-Stage Development and Production of BiondVax’s Universal Flu Vaccine Candidate under Horizon 2020 Initiative	17-06-21	PU
Biondvax Pharmaceuticals : Announces First Quarter 2017 Financial Results and Update	17-05-30	PR

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

All News Biondvax Pharmaceuticals Ltd

Equities

IL0011052045

All News

Filters